SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN) -- Ignore unavailable to you. Want to Upgrade?

To: phbolton who wrote (243)1/25/2000 9:15:00 PM
From: Thomas M.  Read Replies (1) | Respond to of 523
 
AIDD could offer a $100-200 mil in revenues over the next couple of years.

Not too shabby. And PFE continues to endorse NRGN heavily.

Tom



To: phbolton who wrote (243)1/26/2000 1:30:00 AM
From: Doc Bones  Respond to of 523
 
...I also thought that the eyeglass post was inane as it contained zero information.

"Where is the life we have lost in living?
Where is the wisdom we have lost to knowledge?
Where is the knowledge we have lost to information?"

T S Eliot "The Rock" 1934(!)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News